<DOC>
	<DOCNO>NCT02020928</DOCNO>
	<brief_summary>Setting : Oral mucositis common complication cancer treatment , accounting , often increase risk infection even interruption treatment , interfere prognosis disease . The low intensity laser therapy propose alternative treatment prevention side effect , good result term clinical functional , speed process wound heal reduce pain . Objective : To evaluate effectiveness use low power laser prevention oral mucositis patient hematological cancer , undergo chemotherapy bone marrow transplantation . Methods : There Clinical Trial Randomized , double-blind study evaluate effectiveness use low power laser prevention oral mucositis patient hematological cancer , undergo chemotherapy bone marrow transplantation . Participate study , patient condition mention accept participate age 18 . Will exclude study patient autoimmune disease , present sensitivity laser already start treatment oral mucositis prior study.The study variable : -independent variable : whether red laser low power-dependent variable : oral mucositis , degree mucositis , chemotherapy regimen , type blood cancer . For determine association independent variable dependent use chi-square test association ( Pearson ) Fisher 's exact test , necessary . Will calculate risk ratio ( RR ) measure relative risk , confidence interval 95 % ( IC95 % ) .Also calculate NNT ( number need treat obtain benefit ) NNH ( number need harm get ) . Will adopt significance level 5 % . The project approve Ethics Research iMIP . All patient appropriately informed objective project include voluntarily agree participate signing consent form . Keywords : laser , prevention control ; oral mucositis , bone marrow transplant .</brief_summary>
	<brief_title>Laser Therapy Prevents Mucositis Oral Chemotherapy Bone Marrow Transplantation ?</brief_title>
	<detailed_description>Inclusion Criteria : patient blood cancer undergo chemotherapy BMT ; patient agree participate ; patient older 18 year . Exclusion Criteria : patient autoimmune disease ; patient sensitivity laser ; patient already start treatment mucositis prior research ; HIV-positive patient .</detailed_description>
	<mesh_term>Mucositis</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Stomatitis</mesh_term>
	<mesh_term>Bone Neoplasms</mesh_term>
	<mesh_term>Bone Marrow Neoplasms</mesh_term>
	<criteria>patient hematologic cancer undergo chemotherapy BMT ; patient agree participate ; patient older 18 year . patient autoimmune disease ; patient sensitivity laser ; patient already start treatment mucositis prior research .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Oral Mucositis</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>Bone Marrow Transplantation</keyword>
</DOC>